共 81 条
Efficacy of an Internet- and Mobile-Based Intervention for Subclinical Anxiety and Depression (ICare Prevent) with Two Guidance Formats: Results from a Three-Armed Randomized Controlled Trial
被引:2
作者:
Zarski, Anna-Carlotta
[1
,2
]
Weisel, Kiona K.
[2
]
Berger, Thomas
[3
]
Krieger, Tobias
[3
]
Schaub, Michael P.
[4
]
Berking, Matthias
[2
]
Goerlich, Dennis
[5
]
Jacobi, Corinna
[6
]
Ebert, David D.
[7
]
机构:
[1] Philipps Univ Marburg, Dept Clin Psychol, Div Ehlth Clin Psychol, Marburg, Germany
[2] Friedrich Alexander Univ Erlangen Nurnberg, Dept Clin Psychol & Psychotherapy, Erlangen, Germany
[3] Univ Bern, Dept Clin Psychol & Psychotherapy, Bern, Switzerland
[4] Univ Zurich, Swiss Res Inst Publ Hlth & Addict ISGF, Swiss Res Inst Publ Hlth & Addict ISGF, Zurich, Switzerland
[5] Univ Munster, Inst Biostat & Clin Res, Munster, Germany
[6] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany
[7] Tech Univ Munich, Professorship Psychol & Digital Mental Hlth Care, Munich, Germany
关键词:
Internet intervention;
Transdiagnostic prevention;
Subthreshold disorders;
Subclinical anxiety;
Subclinical depression;
SUBTHRESHOLD DEPRESSION;
PSYCHOMETRIC PROPERTIES;
BEHAVIORAL ACTIVATION;
STRESS-MANAGEMENT;
MINOR DEPRESSION;
MENTAL-HEALTH;
AUDIT-C;
METAANALYSIS;
SCALE;
VALIDATION;
D O I:
10.1159/000536149
中图分类号:
R749 [精神病学];
学科分类号:
100205 ;
摘要:
Introduction: Limited research exists on intervention efficacy for comorbid subclinical anxiety and depressive disorders, despite their common co-occurrence. Internet- and mobile-based interventions (IMIs) are promising to reach individuals facing subclinical symptoms. Objective: This study aimed to evaluate the efficacy of a transdiagnostic and self-tailored IMI in reducing subclinical anxiety and depressive symptom severity with either individualized (IG-IMI) or automated (AG-IMI) guidance compared to a waitlist control group with care-as-usual access (WLC). Methods: Participants included 566 adults with subclinical anxiety (GAD-7 >= 5) and/or depressive (CES-D >= 16) symptoms, who did not meet criteria for a full-syndrome depressive or anxiety disorder. In a three-arm randomized clinical trial, participants were randomized to a cognitive behavioral 7-session IMI plus booster session with IG-IMI (n = 186) or AG-IMI (n = 189) or WLC (n = 191). Primary outcomes included observer-rated anxiety (HAM-A) and depressive (QIDS) symptom severity 8 weeks after randomization assessed by blinded raters via telephone. Follow-up outcomes at 6 and 12 months are reported. Results: Symptom severity was significantly lower with small to medium effects in IG-IMI (anxiety: d = 0.45, depression: d = 0.43) and AG-IMI (anxiety: d = 0.31, depression: d = 0.32) compared to WLC. No significant differences emerged between guidance formats in primary outcomes. There was a significant effect in HAM-A after 6 months favoring AG-IMI. On average, participants completed 85.38% of IG-IMI and 77.38% of AG-IMI. Conclusions: A transdiagnostic, self-tailored IMI can reduce subclinical anxiety and depressive symptom severity, but 12-month long-term effects were absent. Automated guidance holds promise for enhancing the scalability of IMIs in broad prevention initiatives.
引用
收藏
页码:155 / 168
页数:14
相关论文